Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clifford W Shults

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Mitochondrion|August 27, 2005
Mitochondrial dysfunction and possible treatments in Parkinson's disease--a reviewClifford W Shults
Pharmacology & Therapeutics|June 21, 2005
Therapeutic role of coenzyme Q(10) in Parkinson's diseaseClifford W Shults
Archives of Neurology|December 17, 2003
Treatments of Parkinson disease: circa 2003Clifford W Shults
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2006
Lewy bodiesClifford W Shults
Current Medicinal Chemistry|July 23, 2003
Coenzyme Q10 in neurodegenerative diseasesClifford W Shults
Experimental Neurology|January 5, 2002
Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson's diseaseKyoko Tsuboi, Clifford W Shults
Neuroscience Letters|August 12, 2006
alpha-synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophyClifford W Shults, Jennifer M Barrett, Deborah Fontaine
Experimental Neurology|July 13, 2004
Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's diseaseClifford W Shults, M Flint Beal, David Song, et al.
Experimental Neurology|March 18, 2004
Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTPDavid D Song, Clifford W Shults, Abbyann Sisk, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 29, 2009
Dopamine depletion induces distinct compensatory gene expression changes in DARPP-32 signal transduction cascades of striatonigral and striatopallidal neuronsBernhard H Meurers, Gustavo Dziewczapolski, Tao Shi, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Mitochondrion|August 27, 2005
Mitochondrial dysfunction and possible treatments in Parkinson's disease--a reviewClifford W Shults
Pharmacology & Therapeutics|June 21, 2005
Therapeutic role of coenzyme Q(10) in Parkinson's diseaseClifford W Shults
Archives of Neurology|December 17, 2003
Treatments of Parkinson disease: circa 2003Clifford W Shults
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2006
Lewy bodiesClifford W Shults
Current Medicinal Chemistry|July 23, 2003
Coenzyme Q10 in neurodegenerative diseasesClifford W Shults
Experimental Neurology|January 5, 2002
Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson's diseaseKyoko Tsuboi, Clifford W Shults
Neuroscience Letters|August 12, 2006
alpha-synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophyClifford W Shults, Jennifer M Barrett, Deborah Fontaine
Experimental Neurology|July 13, 2004
Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's diseaseClifford W Shults, M Flint Beal, David Song, et al.
Experimental Neurology|March 18, 2004
Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTPDavid D Song, Clifford W Shults, Abbyann Sisk, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 29, 2009
Dopamine depletion induces distinct compensatory gene expression changes in DARPP-32 signal transduction cascades of striatonigral and striatopallidal neuronsBernhard H Meurers, Gustavo Dziewczapolski, Tao Shi, et al.
Pageof 3